-
Pharma MSMEs seek government intervention to tackle shortage, price increase of raw materials
expresspharma
March 17, 2021
Caution that if the situation continues, there could be a scarcity of medicines in the country.
-
C2 PHARMA Completes Multiple Regulatory Filings, Expands API Portfolio to Solidify Position as a Leading Ophthalmic API Supplier to the Pharmaceutical Industry
PharmaSources.com
February 24, 2021
Luxembourg, February 23, 2021 – C2 PHARMA, a pharmaceutical group established in 2014 focused on niche active pharmaceutical ingredient (APIs), has expanded its portfolio of APIs and botanical extracts throughout 2020.
-
Cascade Chemistry Initiates Expansion of cGMP Manufacturing Capacity
americanpharmaceuticalreview
February 23, 2021
Cascade Chemistry announced initiation of construction of new facilities designed to increase the company’s capacity to manufacture APIs (active pharmaceutical ingredients) under cGMP (current Good Manufacturing Practices standards and procedures).
-
Wavelength Pharmaceuticals Acquires Majority Stake in Vanamali Organics
contractpharma
February 20, 2021
Wavelength Pharmaceuticals, a developer and manufacturer of active pharmaceutical ingredients (APIs), has acquired a majority stake in Vanamali Organics Pvt. Ltd. of Telangana, India.
-
Cascade Chemistry Begins $14M cGMP Mfg. Capacity Expansion
contractpharma
February 20, 2021
Cascade Chemistry, a pharmaceutical CDMO, began construction of new facilities to increase capacity to manufacture APIs under cGMP.
-
Lonza Expands Solid Small Molecule Services
contractpharma
February 18, 2021
To encompass all aspects of solid form screening and characterization of small molecule APIs.
-
TCG Lifesciences Expands Footprint to the U.S.
contractpharma
February 09, 2021
TCG Lifesciences Pvt. Ltd., a company controlled by New York-based The Chatterjee Group, has expanded its operations in the U.S. with the establishment of TCG GreenChem Inc., a subsidiary of TCG Lifesciences to provide contract development and ...
-
Sai Life Sciences Expands Capabilities
contractpharma
February 01, 2021
Sai Life Sciences, a contract research, development and manufacturing organization (CRDMO), has unveiled plans to double its headcount and expand its suite of technical capabilities at its Manchester, UK site, a center of excellence for active ...
-
SeQuent Scientific gets CEP for its generic API Diclazuril in EU
expresspharma
January 29, 2021
Diclazuril is an antiprotozoal drug to treat coccidiosis in livestock and equine protozoal myeloencephalitis caused by Sarcocystis neurona in horses.
-
DCGI calls for suggestions from industry to reduce compliance burden
expresspharma
January 29, 2021
The Drug Controller General of India (DCGI) has asked industry associations to submit their representations highlighting aspects or issues in the Drug and Cosmetics Rule 1945 that can be made redundant to reduce the compliance burden on the industry.